Home » Newsletters » BioWorld Science

BioWorld Science

July 9, 2001

View Archived Issues

Licensing opportunity from NIH: novel antitumor macrocyclic lactones

PowderJect's vaccine pipeline continues to advance

Statin-based LFA-1 inhibitor designed at Novartis for use in inflammation, autoimmune diseases

Enhanced insulin sensitivity obtained in insulin-resistant obese rats treated with BIM-23268

Recent advances in the development of selective aggrecanase inhibitors

Fluad significantly better than nonadjuvanted flu vaccine against pandemic flu virus strain

Positive Seroquel data presented at Conference on Bipolar Disorder

Antagonist of hTSH and hTSI engineered in Israel as potential treatment for hyperthyroidism

First evidence that topical antisense drug penetrates psoriatic lesions

Betatropin: a new approach to type 2 diabetes discussed at recent scientific meetings

Novartis sells rights to five CNS products to Mallinckrodt

Drop in disease progression on Casodex reported in prostate cancer trial

Tanabe Seiyaku licenses DDS technologies to aaiPharma

Insulin sensitizer licensed out by Roche to Kowa

Heterocyclic compounds with activity at alpha1-adrenoceptors and several 5-HT receptors

Atridox receives approval in Switzerland

Safe intracerebroventricular doses of huperzine A determined in animals

New salt of carvedilol with improved water solubility

Janssen patents new triazole protein farnesyltransferase inhibitors

Thyroid receptor antagonists and their use disclosed by Karo Bio in recent patent

Two patents cover P2T antagonists discovered at AstraZeneca

Dengue subgenomic replicons available for licensing from NIH

Naftidrofuryl effective and safe in patients with vascular or mixed dementia

Bayer HBV compound available for licensing worldwide

Melatonin has beneficial effects on sleep quality and Hb1Ac in type 2 diabetics

Company Profile: DrugAbuse Sciences

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...